{"title":"基于 18F-FDG PET 放射组学、代谢参数和临床因素的老年 DLBCL 患者预后模型的开发与验证。","authors":"Tianshuo Yang, Zhuxu Sun, Yuye Shi, Yue Teng, Luyi Cheng, Ronghua Zhu, Huai Zhang, Qiuhu Wang, Jing Wei, Chongyang Ding, Weijing Tao","doi":"10.1007/s00277-024-06071-6","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to assess the predictive value of baseline <sup>18</sup>F-FDG PET radiomics features, metabolic parameters, and clinical factors for PFS and OS in elderly DLBCL patients. Using LASSO COX regression, we derived Radscore from PET radiomics features. We constructed and externally validated prognostic models, evaluating their performance through various metrics. From 341 training set patients and 83 external validation set patients revealed significant correlations between PET radiomics features and survival outcomes. Multivariate COX analysis identified associations of radiomics features (Radscore), metabolic parameters (TMTV, Dmax), and clinical factors (ECOG PS, hemoglobin level) with PFS and OS. In external validation, the combined model incorporating radiomic features, metabolic parameters, and clinical factors showed superior predictive performance for PFS and OS compared to other models. The combined model had higher C-index values for both PFS and OS, and its td-ROC curves exhibited significantly higher AUCs. Calibration curves demonstrated good consistency, and DCA revealed a higher net benefit for the combined model. In conclusion, the combined model that incorporated <sup>18</sup>F-FDG PET radiomics features, metabolic parameters, and clinical factors demonstrated superior prognostic predictive ability, providing a useful tool for personalized treatment decisions in elderly DLBCL patients.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and validation of prognostic models based on <sup>18</sup>F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients.\",\"authors\":\"Tianshuo Yang, Zhuxu Sun, Yuye Shi, Yue Teng, Luyi Cheng, Ronghua Zhu, Huai Zhang, Qiuhu Wang, Jing Wei, Chongyang Ding, Weijing Tao\",\"doi\":\"10.1007/s00277-024-06071-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study aimed to assess the predictive value of baseline <sup>18</sup>F-FDG PET radiomics features, metabolic parameters, and clinical factors for PFS and OS in elderly DLBCL patients. Using LASSO COX regression, we derived Radscore from PET radiomics features. We constructed and externally validated prognostic models, evaluating their performance through various metrics. From 341 training set patients and 83 external validation set patients revealed significant correlations between PET radiomics features and survival outcomes. Multivariate COX analysis identified associations of radiomics features (Radscore), metabolic parameters (TMTV, Dmax), and clinical factors (ECOG PS, hemoglobin level) with PFS and OS. In external validation, the combined model incorporating radiomic features, metabolic parameters, and clinical factors showed superior predictive performance for PFS and OS compared to other models. The combined model had higher C-index values for both PFS and OS, and its td-ROC curves exhibited significantly higher AUCs. Calibration curves demonstrated good consistency, and DCA revealed a higher net benefit for the combined model. In conclusion, the combined model that incorporated <sup>18</sup>F-FDG PET radiomics features, metabolic parameters, and clinical factors demonstrated superior prognostic predictive ability, providing a useful tool for personalized treatment decisions in elderly DLBCL patients.</p>\",\"PeriodicalId\":8068,\"journal\":{\"name\":\"Annals of Hematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00277-024-06071-6\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-024-06071-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
本研究旨在评估基线18F-FDG PET放射组学特征、代谢参数和临床因素对老年DLBCL患者PFS和OS的预测价值。利用 LASSO COX 回归,我们从 PET 放射性组学特征得出了 Radscore。我们构建了预后模型并进行了外部验证,通过各种指标评估其性能。从341名训练集患者和83名外部验证集患者中发现,PET放射组学特征与生存结果之间存在显著相关性。多变量 COX 分析确定了放射组学特征(Radscore)、代谢参数(TMTV、Dmax)和临床因素(ECOG PS、血红蛋白水平)与 PFS 和 OS 的相关性。在外部验证中,与其他模型相比,包含放射学特征、代谢参数和临床因素的组合模型对PFS和OS的预测性能更优。组合模型对PFS和OS的C指数值更高,其td-ROC曲线的AUC也明显更高。校准曲线显示出良好的一致性,DCA显示组合模型的净获益更高。总之,结合了18F-FDG PET放射组学特征、代谢参数和临床因素的联合模型显示出了卓越的预后预测能力,为老年DLBCL患者的个性化治疗决策提供了有用的工具。
Development and validation of prognostic models based on 18F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients.
This study aimed to assess the predictive value of baseline 18F-FDG PET radiomics features, metabolic parameters, and clinical factors for PFS and OS in elderly DLBCL patients. Using LASSO COX regression, we derived Radscore from PET radiomics features. We constructed and externally validated prognostic models, evaluating their performance through various metrics. From 341 training set patients and 83 external validation set patients revealed significant correlations between PET radiomics features and survival outcomes. Multivariate COX analysis identified associations of radiomics features (Radscore), metabolic parameters (TMTV, Dmax), and clinical factors (ECOG PS, hemoglobin level) with PFS and OS. In external validation, the combined model incorporating radiomic features, metabolic parameters, and clinical factors showed superior predictive performance for PFS and OS compared to other models. The combined model had higher C-index values for both PFS and OS, and its td-ROC curves exhibited significantly higher AUCs. Calibration curves demonstrated good consistency, and DCA revealed a higher net benefit for the combined model. In conclusion, the combined model that incorporated 18F-FDG PET radiomics features, metabolic parameters, and clinical factors demonstrated superior prognostic predictive ability, providing a useful tool for personalized treatment decisions in elderly DLBCL patients.
期刊介绍:
Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.